Team:UCL/Tests

From 2014.igem.org

(Difference between revisions)
Line 44: Line 44:
                 <th> Registry ID </th>
                 <th> Registry ID </th>
                 <th> Name / Function </th>
                 <th> Name / Function </th>
 +
                <th> Antibiotic Resistance </th>
                 <th> Source </th>
                 <th> Source </th>
                 <th> Size </th>
                 <th> Size </th>
Line 52: Line 53:
                 <td> <center>U</center> </td>
                 <td> <center>U</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K314103">BBa_K314103</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K314103">BBa_K314103</a> </td>
-
                 <td> &nbsp;IPTG-inducible LacI Expression Cassette (chloramphenicol resistant) </td>
+
                 <td> &nbsp;IPTG-inducible LacI Expression Cassette </td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 1, Well 4D.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 1, Well 4D.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K314103">1638 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K314103">1638 bp</a> </td>
Line 59: Line 61:
                 <td> <center>T</center> </td>
                 <td> <center>T</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_J04450">BBa_J04450</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_J04450">BBa_J04450</a> </td>
-
                 <td> &nbsp;RFP Coding Device (chloramphenicol resistant) </td>
+
                 <td> &nbsp;RFP Coding Device </td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 4, Well 4B. </td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 4, Well 4B. </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_J04450">1069 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_J04450">1069 bp</a> </td>
Line 66: Line 69:
                 <td> <center>T</center> </td>
                 <td> <center>T</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_R0010">BBa_R0010</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_R0010">BBa_R0010</a> </td>
-
                 <td> &nbsp;IPTG-inducible LacI Promoter (chloramphenicol resistant) </td>
+
                 <td> &nbsp;IPTG-inducible LacI Promoter</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 3, Well 4G.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 3, Well 4G.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_R0010">200 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_R0010">200 bp</a> </td>
Line 73: Line 77:
                 <td> <center>T</center> </td>
                 <td> <center>T</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> </td>
-
                 <td> &nbsp;Ribosomal Binding Site (RBS) (chloramphenicol resistant) </td>
+
                 <td> &nbsp;Ribosomal Binding Site (RBS)</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 4, Well 1N.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 4, Well 1N.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_B0034">12 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_B0034">12 bp</a> </td>
Line 80: Line 85:
                 <td> <center>T</center> </td>
                 <td> <center>T</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K518012">BBa_K518012</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K518012">BBa_K518012</a> </td>
-
                 <td> &nbsp;RBS + RFP + double Terminator (chloramphenicol resistant) </td>
+
                 <td> &nbsp;RBS + RFP + double Terminator</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 1, Well 18C.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 1, Well 18C.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K518012">828 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K518012">828 bp</a> </td>
Line 87: Line 93:
                 <td> <center>N</center> </td>
                 <td> <center>N</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K206000">BBa_K206000</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_K206000">BBa_K206000</a> </td>
-
                 <td> &nbsp;pBAD Strong Promoter (chloramphenicol resistant) </td>
+
                 <td> &nbsp;pBAD Strong Promoter</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 3, Well 14A.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 3, Well 14A.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K206000">130 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_K206000">130 bp</a> </td>
Line 94: Line 101:
                 <td> <center>! N</center> </td>
                 <td> <center>! N</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_R0011">BBa_R0011</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_R0011">BBa_R0011</a> </td>
-
                 <td> &nbsp;LacI-Regulated, Lambda pL Hybrid Promoter (chloramphenicol resistant) </td>
+
                 <td> &nbsp;LacI-Regulated, Lambda pL Hybrid Promoter</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 2, Well 6D.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 2, Well 6D.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_R0011">55 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_R0011">55 bp</a> </td>
Line 101: Line 109:
                 <td> <center>! N</center> </td>
                 <td> <center>! N</center> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_B0012">BBa_B0012</a> </td>
                 <td> &nbsp;<a href="http://parts.igem.org/Part:BBa_B0012">BBa_B0012</a> </td>
-
                 <td> &nbsp;Transcription Terminator for E. coli RNA Polymerase (chloramphenicol resistant) </td>
+
                 <td> &nbsp;Transcription Terminator for E. coli RNA Polymerase</td>
 +
                <td> &nbsp;Chloramphenicol</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 2, Well 2B.</td>
                 <td> &nbsp;Spring 2014 BioBrick Distribution. Plate 2, Well 2B.</td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_B0012">41 bp</a> </td>
                 <td> &nbsp;<a href="/Team:UCL/Science/Sequences#BBa_B0012">41 bp</a> </td>

Revision as of 17:26, 16 October 2014

Goodbye Azodye UCL iGEM 2014

Experiments

Stage 01: Extraction of useful BioBrick plasmids from iGEM 2014 Distribution Kit


We began our project by identifying a range of BioBrick parts present in the iGEM 2014 distribution kit which we required as part of our cloning strategy. These parts primarily consisted of both constituitive and inducible promoter systems with ribosome binding sites which we could then use in conjunction with our azo-reductase BioBricks to assemble a functional azo dye degrading gene. We also decided that we would use the Red Florescent Protein expressing BioBrick as a control for any further transformation experiments. As the level of DNA present within each plate of the distribution kit is insufficient to perform digest and ligation reactions on it was necessary to transform each of these plasmids into our NEB5alpha competent cells. After growing our transformed cells overnight we then mini-prepped each of them to obtain BioBrick plasmids at suitable concentrations for future experiments.


Registry ID Name / Function Antibiotic Resistance Source Size
U
 BBa_K314103  IPTG-inducible LacI Expression Cassette  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 1, Well 4D.  1638 bp
T
 BBa_J04450  RFP Coding Device  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 4, Well 4B.  1069 bp
T
 BBa_R0010  IPTG-inducible LacI Promoter  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 3, Well 4G.  200 bp
T
 BBa_B0034  Ribosomal Binding Site (RBS)  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 4, Well 1N.  12 bp
T
 BBa_K518012  RBS + RFP + double Terminator  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 1, Well 18C.  828 bp
N
 BBa_K206000  pBAD Strong Promoter  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 3, Well 14A.  130 bp
! N
 BBa_R0011  LacI-Regulated, Lambda pL Hybrid Promoter  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 2, Well 6D.  55 bp
! N
 BBa_B0012  Transcription Terminator for E. coli RNA Polymerase  Chloramphenicol  Spring 2014 BioBrick Distribution. Plate 2, Well 2B.  41 bp
Note: U = Used in experiments; T = Used for testing purposes but not for making BioBrick Devices; N = Transformed from Distribution Kits, but not used in experiments; ! = Problematic parts (see Parts Registry), were not used.

Stage 02: Identification of useful genes for making new BioBricks


Extraction of Bacillus subtilis genomic DNA
Protocols   DNA extraction

Our literature search identified a number of bacterial species that have been proven to degrade azo dye compounds including B. subtilis and P. aeruginosa. We were able to obtain a B. subtilis strain for use in our project from ?. We extracted the genomic DNA from this strain using a Promega Wizard Genomic DNA extraction kit so that we could subsequently amplify the azo-reducatase gene (AzoR1) and create our first azo-reductase BioBrick. After completing the genomic DNA extracton we ran a gel to show that we had successfully extracted the B. subtilis genomic DNA.


Stage 03: Transforming E. coli with azo-reductase plasmids


We were gratefully provided with a set of five plasmids from the Microbial & Enzyme Technology Lab led by Dr Lígia O. Martins at the Universidade Nova de Lisboa. They are currently researching how azo-dye degrading enzymes function and are keen to collaborate with us. These plasmids contained a number of genes encoding azo-dye degrading enzymes from both B. subtilis and P. putida including mutated forms found to exhibit enhanced degradation activity. As the DNA concentration of the plasmids we were sent was insufficient to perform PCR amplification on we transformed each of these plasmids into our E. coli NEB5alpha derivative competent cells. After growing the cells overnight we then mini-prepped each of them to obtain plasmids at sufficient concentrations for future experimental work.

Gene ID Name / Function Source Size Plasmid
 pAzoR  FMN-dependent NADH-azoreductase 1  Pseudomonas putida  612 bp  In expression vector: pET-21a (+) (ampicillin resistant) [2] [3] ,
initially cloned between NdeI and BamHI restriction sites.
 p1B6  AzoR heat-stable mutant  Pseudomonas putida  612 bp  [In Progress]: to remove 2 illegal PstI sites
 pCotA  Spore Coat Protein Laccase  Bacillus subtilis  1542 bp  [In Progress]: primers designed
 pBsDyP  Dye Decolourising Peroxidase BSU38260  Bacillus subtilis  1251 bp  [New BioBrick Part]: submitted
 pPpDyP  Dye Decolourising Peroxidase PP_3248  Pseudomonas putida  864 bp  [In Progress]: primers designed

Stage 04: Diagnostic digest of azo-reductase plasmids


...


Stage 05: Creation of azo-reductase BioBrick parts from plasmids


...


Stage 06: Diagnostic digest of azo-reductase BioBrick parts


...


Stage 07: Assembling azo-reductase BioBrick Device(s)


...


Registry ID Gene ID Name / Function Source Size Status
 BBa_K1336000  AzoR  FMN-dependent NADH-azoreductase 1  Pseudomonas putida  612 bp  [In Progress]: primers designed
 BBa_K1336001  1B6  AzoR heat-stable mutant  Pseudomonas putida  612 bp  [In Progress]: to remove 2 illegal PstI sites
 BBa_K1336002  CotA  Spore Coat Protein Laccase  Bacillus subtilis  1542 bp  [In Progress]: primers designed
 BBa_K1336003  BsDyP  Dye Decolourising Peroxidase BSU38260  Bacillus subtilis  1251 bp  [New BioBrick Part]: submitted
 BBa_K1336004  PpDyP  Dye Decolourising Peroxidase PP_3248  Pseudomonas putida  864 bp  [In Progress]: primers designed
 BBa_K1336005  ispB RNAi  RNAi of Octaprenyl Diphosphate
Synthase fragment
 Escherichia coli, K12 strain  562 bp  [New BioBrick Part]: submitted
 BBa_K1336006  LacIEC+ispB  IPTG inducible ispB RNAi  Escherichia coli, K12 strain  2208 bp  [New BioBrick Device]: submitted
 BBa_K1336007  LacIEC+BsDyP  IPTG inducible BsDyP  Bacillus subtilis  2895 bp  [New BioBrick Device]: submitted
 BBa_K729006  CueO  Laccase  Escherichia coli  1612 bp  [In Progress]: ascertaining identity
()
 BBa_K500000  LiP  Lignin Peroxidase  Phanerochaete chrysosporium  1116 bp  [Improved Characterisation]: toxicity issues in gene synthesis.
 [In Progress]: to subclone into pSB1C3/pSB3C5.
 BBa_K729004  nucB  Extracellular nuclease  Staphylococcus aureus  561 bp  [Improved Function]

Stage 08: Characterisation of azo-reductase BioBrick devices


...


Contact Us

University College London
Gower Street - London
WC1E 6BT
Biochemical Engineering Department
Phone: +44 (0)20 7679 2000
Email: ucligem2014@gmail.com

Follow Us